Fagan Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.8M | Buy |
54,265
+401
| +0.7% | +$93.5K | 1.7% | 15 |
|
|
2026
Q1 | $13.2M | Sell |
53,864
-169
| -0.3% | -$39.4K | 1.83% | 15 |
|
|
2025
Q4 | $11.2M | Buy |
54,033
+93
| +0.2% | +$18.4K | 1.49% | 21 |
|
|
2025
Q3 | $10M | Buy |
53,940
+1,441
| +3% | +$247K | 1.38% | 23 |
|
|
2025
Q2 | $8.02M | Buy |
52,499
+1,435
| +3% | +$221K | 1.24% | 27 |
|
|
2025
Q1 | $8.47M | Sell |
51,064
-683
| -1% | -$107K | 1.41% | 21 |
|
|
2024
Q4 | $7.48M | Sell |
51,747
-719
| -1% | -$111K | 1.19% | 25 |
|
|
2024
Q3 | $8.5M | Buy |
52,466
+44
| +0.1% | +$7.01K | 1.43% | 20 |
|
|
2024
Q2 | $7.66M | Sell |
52,422
-626
| -1% | -$93.1K | 1.34% | 22 |
|
|
2024
Q1 | $8.39M | Buy |
53,048
+1,851
| +4% | +$295K | 1.57% | 19 |
|
|
2023
Q4 | $8.02M | Buy |
51,197
+2,066
| +4% | +$317K | 1.74% | 17 |
|
|
2023
Q3 | $7.65M | Buy |
49,131
+1,283
| +3% | +$212K | 1.85% | 18 |
|
|
2023
Q2 | $7.92M | Buy |
47,848
+586
| +1% | +$94.6K | 1.92% | 15 |
|
|
2023
Q1 | $7.33M | Buy |
47,262
+337
| +0.7% | +$54.4K | 1.82% | 17 |
|
|
2022
Q4 | $8.29M | Buy |
46,925
+643
| +1% | +$111K | 2.21% | 11 |
|
|
2022
Q3 | $7.56M | Buy |
46,282
+145
| +0.3% | +$24.5K | 2.11% | 10 |
|
|
2022
Q2 | $8.19M | Buy |
46,137
+877
| +2% | +$156K | 2.19% | 7 |
|
|
2022
Q1 | $8.02M | Buy |
45,260
+279
| +0.6% | +$47.5K | 1.65% | 18 |
|
|
2021
Q4 | $7.7M | Buy |
44,981
+1,289
| +3% | +$211K | 1.46% | 20 |
|
|
2021
Q3 | $7.06M | Buy |
43,692
+689
| +2% | +$118K | 1.53% | 18 |
|
|
2021
Q2 | $7.08M | Sell |
43,003
-26
| -0.1% | -$4.3K | 1.51% | 19 |
|
|
2021
Q1 | $7.07M | Buy |
43,029
+915
| +2% | +$148K | 1.65% | 19 |
|
|
2020
Q4 | $6.63M | Buy |
42,114
+1,374
| +3% | +$203K | 1.66% | 17 |
|
|
2020
Q3 | $6.07M | Buy |
40,740
+1,332
| +3% | +$197K | 1.74% | 15 |
|
|
2020
Q2 | $5.54M | Buy |
39,408
+903
| +2% | +$132K | 1.77% | 14 |
|
|
2020
Q1 | $5.05M | Buy |
38,505
+1,806
| +5% | +$256K | 2.01% | 16 |
|
|
2019
Q4 | $5.35M | Sell |
36,699
-272
| -0.7% | -$36.9K | 1.74% | 17 |
|
|
2019
Q3 | $4.78M | Buy |
36,971
+1,104
| +3% | +$145K | 1.85% | 18 |
|
|
2019
Q2 | $5M | Buy |
35,867
+611
| +2% | +$84.6K | 2.03% | 14 |
|
|
2019
Q1 | $4.93M | Buy |
35,256
+5,858
| +20% | +$785K | 2.11% | 14 |
|
|
2018
Q4 | $3.79M | Buy |
29,398
+8,322
| +39% | +$1.16M | 1.95% | 13 |
|
|
2018
Q3 | $2.91M | Buy |
21,076
+73
| +0.3% | +$9.7K | 1.2% | 27 |
|
|
2018
Q2 | $2.55M | Buy |
21,003
+138
| +0.7% | +$17.2K | 1.14% | 26 |
|
|
2018
Q1 | $26.8K | Buy |
20,865
+477
| +2% | +$64.5K | 11.42% | 1 |
|
|
2017
Q4 | $2.85K | Sell |
20,388
-116
| -0.6% | -$16.2K | 1.15% | 28 |
|
|
2017
Q3 | $2.67M | Sell |
20,504
-97
| -0.5% | -$12.9K | 1.32% | 29 |
|
|
2017
Q2 | $2.73M | Buy |
20,601
+713
| +4% | +$91K | 1.42% | 24 |
|
|
2017
Q1 | $2.48M | Buy |
19,888
+99
| +0.5% | +$11.8K | 1.37% | 23 |
|
|
2016
Q4 | $2.28M | Buy |
19,789
+535
| +3% | +$61.8K | 1.32% | 28 |
|
|
2016
Q3 | $2.27M | Sell |
19,254
-134
| -0.7% | -$16.3K | 1.39% | 27 |
|
|
2016
Q2 | $2.35M | Sell |
19,388
-293
| -1% | -$33.3K | 1.51% | 23 |
|
|
2016
Q1 | $2.13M | Buy |
19,681
+1,010
| +5% | +$105K | 1.41% | 25 |
|
|
2015
Q4 | $1.92M | Buy |
18,671
+98
| +0.5% | +$9.86K | 1.27% | 28 |
|
|
2015
Q3 | $1.73M | Sell |
18,573
-554
| -3% | -$53.6K | 1.27% | 27 |
|
|
2015
Q2 | $1.86M | Buy |
19,127
+559
| +3% | +$56K | 1.24% | 27 |
|
|
2015
Q1 | $1.87M | Buy |
18,568
+5,427
| +41% | +$552K | 1.38% | 27 |
|
|
2014
Q4 | $1.37M | Buy |
13,141
+139
| +1% | +$14.6K | 1.09% | 30 |
|
|
2014
Q3 | $1.39M | Sell |
13,002
-80
| -0.6% | -$8.3K | 1.14% | 30 |
|
|
2014
Q2 | $1.37M | Sell |
13,082
-385
| -3% | -$38.9K | 1.17% | 29 |
|
|
2014
Q1 | $1.32M | Buy |
+13,467
| New | +$1.25M | 1.15% | 30 |
|
Other funds holding JNJ
Fagan Associates's JNJ Position: Q2 2026 in Review
Fagan Associates increased its Johnson & Johnson (JNJ) stake by 0.74% in Q2 2026, buying an estimated $93.5K and bringing the position to 54,265 shares worth $13.8M. The position accounts for 1.7% of the portfolio, ranked #15.
Fagan Associates first reported a position in JNJ in Q1 2014 and has held it in 50 quarters since. 2,967 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Fagan Associates held 54,265 shares of Johnson & Johnson worth $13.8M as of Q2 2026.
- Fagan Associates bought 401 Johnson & Johnson shares in Q2 2026, an estimated $93.5K.
- Johnson & Johnson made up 1.7% of Fagan Associates's portfolio in Q2 2026, its #15 holding.
- Fagan Associates first reported a position in Johnson & Johnson in Q1 2014 and has held it in 50 quarters since.
- 2,967 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Fagan Associates's 13F filing for Q2 2026, filed 4 Aug 2026.